00:00
00:00
00:00
Valirx - VAL201 Clinical Trials

Dr George Morris, COO of Valirx, discusses the latest announcement on VAL201 and how the company is able to proceed after receiving the approval for the acceleration of the trial and to substantially escalate the dose, which is a pivotal and substantial breakthrough for their lead compound.

Dr George Morris
Chief Operating Officer

Company Events - VALIRX PLC